Oramed Pharmaceuticals
ORMP
ORMP
93 hedge funds and large institutions have $119M invested in Oramed Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 39 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
24% more funds holding
Funds holding: 75 → 93 (+18)
4.41% more ownership
Funds ownership: 12.24% → 16.65% (+4.4%)
Holders
93
Holding in Top 10
1
Calls
$11.1M
Puts
$6.13M
Top Buyers
| 1 | +$16.3M | |
| 2 | +$3.6M | |
| 3 | +$2.99M | |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
+$2.91M |
| 5 |
JC
Jetstream Capital
Brentwood,
Tennessee
|
+$2.64M |
Top Sellers
| 1 | -$2.9M | |
| 2 | -$2.38M | |
| 3 | -$971K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$565K |
| 5 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
-$451K |